ABBV (ABBV) Stock Price & Analysis
ABBV (ABBV) fell 1.44% to USD 256.46 as of September 8, 2026 at 02:51 UTC, according to Nexqual real-time market data.
ABBV last closed at USD 256.46; the session ranged USD 255.61–258.91 on volume of 4,701,126 shares. Market capitalization is —, with a 52-week range of USD 190.75–267.47 (NYQ). Source: Nexqual, September 8, 2026 at 02:51 UTC.
Key Statistics (as of September 8, 2026 at 02:51 UTC)
| Price | USD 256.46 |
|---|---|
| Change | ▼ 1.44% (down) |
| Previous Close | USD 256.46 |
| Open | USD 256.46 |
| Day Range | USD 255.61 – 258.91 |
| 52-Week Range | USD 190.75 – 267.47 |
| Volume | 4,701,126 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (ABBV)
Nexqual's technical model rates ABBV "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 02:51 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 47.89 (neutral) |
| vs SMA50 | Above (USD 254.48) |
| MACD | 2.3 (positive) |
From ABBV's Latest SEC 10-K Filing (filed 2026-02-20)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ABT | Abbott Laboratories | USD 108.33 | ▼ 1.94% |
| BMY | Bristol-Myers Squibb Company | USD 66.82 | ▼ 1.24% |
| JNJ | Johnson & Johnson | USD 275.23 | ▲ 0.01% |
| GILD | Gilead Sciences, Inc. | USD 151 | ▲ 0.93% |
| MRK | Merck & Company, Inc. | USD 150.33 | ▼ 0.86% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 02:51 UTC. This page is informational and not investment advice.